重症儿科喘的生物疗法:疗效,安全性和生物标志物引导的选择
Enrico Tondina1,2, Alessia Claudia Codazzi2, Riccardo Castorina1
1Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Frontiers in allergy
|February 5, 2026
概括
有针对性的生物疗法对严重的儿科喘有效,改善控制和减少特定生物标志物概况的儿童的恶化. 需要进一步研究长期安全性,成本和获取.
科学领域:
- 免疫生物学的免疫生物学
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
背景情况:
- 严重的儿科喘是一种复杂的,高负担的疾病,治疗反应可变.
- 了解2型 (T2) 炎症途径的进步导致了有针对性的生物疗法.
- 生物学家为患有严重喘的儿童的特定亚组提供新的治疗途径.
研究的目的:
- 审查严重儿科喘中生物疗法的疗效和安全性.
- 为生物标志物驱动的生物选择提供临床指导.
- 讨论儿童喘治疗的未来方向.
主要方法:
- 对生物疗法现有证据的系统审查.
- 对儿科患者群体的疗效和安全数据的分析.
- 综合发现,用于临床应用和未来研究.
主要成果:
- 向生物药物 (抗IgE,抗IL-5/IL-5Rα,抗IL-4Rα,抗TSLP) 改善了喘控制,并减少了部分儿童的恶化.
- 益处在T2高的喘表型中最为明显,通常是通过升高的乙酸盐或FeNO来表示的.
- 虽然肺功能改善很小,但在临床上是显著的;tzepelumab显示了广泛的疗效.
- 在最佳治疗持续时间,停止标准,长期安全性,成本和获取方面仍然存在差距.
结论:
- 生物疗法代表了重症儿科喘精密医学的重大进步.
- 免疫内型和生物标志物选择是优化治疗的关键.
- 未来的优先事项包括定义响应/缓解标准,收集长期安全数据,并确保公平获取.
关键词:
这就是Benralizumab.生物疗法是一种生物疗法.孩子们的孩子们的孩子们的孩子们双重复制的马布.这就是Mepolizumab.在Omalizumab上使用.严重的喘 严重的喘泰泽佩卢姆巴姆的意思是更多相关视频
05:56A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
5.3K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
21.1K
相关概念视频
Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Survey Safety
410
Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
410
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification
4.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.4K
